Calidi Biotherapeutics, Inc. (CLDI) analyst actions
Rating and price-target actions on CLDI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CLDI overview →
1 measured CLDI analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials | Press release | -0.19% | -5.51% |
Keep exploring
More CLDI: earnings → · SEC filings → · CLDI overview →